Image segmentation enables the software to reliably distinguish cells, nuclei and other objects

WALTHAM, Mass., (December 7, 2021)—The scanR high-content screening (HCS) station provides fully automated image acquisition and data analysis. Version 3.3 improves the deep-learning technology’s capabilities to reliably separate objects in biological samples using instance segmentation, the ability to detect and delineate distinct objects of interest in an image.

Reliable Image Segmentation

Using a self-learning microscopy approach, the scanR system’s AI automatically analyzes data in an assay-based workflow. The deep-learning technology can detect cells, nuclei and subcellular objects, and extract features from a list of over 100 object parameters. Version 3.3 significantly improves the deep learning object segmentation capabilities to more accurately segment difficult-to-distinguish objects, such as cells or nuclei that are very close together, like in cell colonies or tissue.

Pretrained Models

In addition to tools to develop neural network models for specific applications, scanR version 3.3 comes with pretrained neural network models for nuclei and cells. These can be used in a broad range of standard applications, including the ability to distinguish between confluent cells and dense nuclei, eliminating the time to train the neural network.

Easier Calibration and Collaboration

Version 3.3 of the scanR software also includes a well plate calibration assistant that makes it fast and simple to calibrate a new well plate for the system. In addition, a new level of license enables collaborators to open, review and re-gate scanR analysis files for easier results sharing.

For more information about the scanR high-content screening station, visit olympus-lifescience.com/microscopes/inverted/scanr/

About Olympus

Olympus is a global technology leader, crafting innovative optical and digital solutions in medical technologies; life sciences; industrial solutions; and cameras and audio products. Throughout our 100-year history, Olympus has focused on being true to society and making people’s lives healthier, safer and more fulfilling.

Our Life Sciences Business is dedicated to meeting and exceeding the evolving needs and expectations of life science professionals through a comprehensive range of clinical, educational and research microscopes and microscope systems. For more information, visit https://www.olympus-lifescience.com and truetolife.com.

Olympus…True to You. True to Society. True to LIFE.

Olympus and the Olympus logo are trademarks of Olympus Corporation or its subsidiaries.

About EVIDENT

In 2022, Olympus Corporation spun off its Scientific Solutions Division, which included its life science and industrial solutions businesses, to establish a new company called Evident. Although our name is different, our expertise, manufacturing capabilities, and commitment to our customers, which defined us over the past 100 years, remain unchanged.

At Evident, innovation and exploration are at the heart of what we do. Committed to making people’s lives healthier, safer, and more fulfilling, we support our customers with solutions that solve their challenges and advance their work; whether it’s researching medical breakthroughs, inspecting infrastructure, or exposing hidden toxins in consumer products.

Evident’s industrial solutions range from microscopes and videoscopes to nondestructive testing equipment and X-ray analyzers for maintenance, manufacturing, and environmental applications. Backed by state-of-the-art technologies, Evident products are widely used for quality control, inspection, and measurement.

In life science, Evident empowers scientists and researchers through collaboration and cutting-edge solutions. We’re dedicated to meeting the challenges and supporting the evolving needs of our customers, continuing to advance a comprehensive range of microscopes for pathology, hematology, IVF, and other clinical applications as well as for research and education.

For more information, visit EvidentScientific.com.